Abstract: Background:Tuberculosis (TB) in humans is caused by bacilli Mycobacterium tuberculosis and Mycobacterium tuberculosis complex. AIDS is an immunodeficiency disease caused by human immunodeficiency virus (HIV) (Mindachew et al., 2014). HIV breaks down the body's defense against infection and immune system by destroying specific white blood cells (CD4 cells) weakening the immune system hence the body cannot fight an illness attack such as tuberculosis (Cook, 2009). Materials and Methods: A descriptive cross sectional study design adopted with the target population being the zero positive patients attending Comprehensive......
Key word: Tuberculosis, HIV, Isoniazid, Therapy
[1]. Abdulalim E, Garuma S, Dibaba B, Chaka. (2017) Isoniazid Preventive Therapy: Level of Adherence and Its Determinant Factors among HIV Positive Patients in Adama Hospital Medical College, Oromia, Ethiopia, 2016.
[2]. Adams, J. A., Anderson, R. A., Docherty, S. L., Tulsky, J. A., Steinhauser, K. E., and Bailey Jr, D. E. (2014). Nursing strategies to support family members of ICU patients at high risk of dying. Heart and Lung, 43(5), 406-415.
[3]. Adepoju, A. V., Ogbudebe, C. L., Adejumo, O. A., Okolie, J., & Inegbeboh, J. O. (2020). Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors. Journal of global infectious diseases, 12(2), 105–111. https://doi.org/10.4103/jgid.jgid_138_18
[4]. Akamike, I. C., Okedo-Alex, I. N., Agu, A. P., Alo, C., and Ogbonnaya, L. U. (2020). Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in Southeast: baseline findings from a quasi-experimental study. The Pan African Medical Journal, 36.
[5]. Akolo, C., Adetifa, I., Shepperd, S., and Volmink, J. (2010). Treatment of latent tuberculosis infection in HIV infected persons.